Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

0.5839
BATS BZX Real-Time Price
As of 10:51am ET
 +0.0132 / +2.31%
Today’s Change
0.55
Today|||52-Week Range
3.79
-59.73%
Year-to-Date
Biotech Stocks Under $5: 2 to Buy, 1 to Avoid
Sep 24 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close0.57
Today’s open0.56
Day’s range0.55 - 0.59
Volume70,197
Average volume (3 months)3,772,068
Market cap$272.8M
Dividend yield--
Data as of 10:51am ET, 09/27/2016

Growth & Valuation

Earnings growth (last year)-78.43%
Earnings growth (this year)+74.73%
Earnings growth (next 5 years)+26.80%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CRBPCorbus Pharmaceutica...-0.29-4.55%
CRHMCRH Medical Corp+0.04+1.07%
OVASOvaScience Inc+0.42+5.25%
CMRXChimerix Inc+0.12+2.14%
Data as of 10:48am ET, 09/27/2016

Financials

Next reporting dateOctober 31, 2016
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$368.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Director, VP &
Head-Investor Relations
Matthew J. Pfeffer
Chief Medical Officer &
Vice President
Raymond W. Urbanski
Corporate headquarters
Valencia, California

Forecasts

Search for Jobs